There is currently no consensus on the optimal management of the infected total hip arthroplasty. Multiple management techniques have been described in contemporary literature.
This paper focuses on 2-stage revision for the infected total hip arthroplasty. We discuss the rationale and examine the current evidence for the use of this technique.
ZmistowskiB., KaramJ.A., DurinkaJ.B., CasperD.S., ParviziJ.Periprosthetic joint infection increases the risk of one-year mortality.J Bone Joint Surg Am.2013; 95(24): 2177–2184.
9.
TomsA.D., DavidsonD., MasriB.A., DuncanC.P.The management of peri-prosthetic infection in total joint arthroplasty.J Bone Joint Surg Br.2006; 88(2): 149–155.
10.
MastersonE.L., MasriB.A., DuncanC.P.Treatment of infection at the site of total hip replacement.Instr Course Lect.1998; 47: 297–306.
11.
GarvinK.L., HinrichsS.H., UrbanJ.A.Emerging antibiotic-resistant bacteria. Their treatment in total joint arthroplasty.Clin Orthop Relat Res.1999; 369: 110–123.
12.
OlsonR., DonnenfeldE., BucciFAJr.Methicillin resistance of Staphylococcus species among health care and nonhealth care workers undergoing cataract surgery.Clin Ophthalmol.2010; 4: 1505–1514.
13.
JamesP.J., ButcherI.A., GardnerE.R., HamblenD.L.Methicillin resistant Staphylococcus epidermidis in infection of hip arthroplasties.J Bone Joint Surg Br.1994; 76(5): 725–727.
14.
ToulsonC., Walcott-SappS., HurJ.Treatment of infected total hip arthroplasty with a 2-stage reimplantation protocol: update on “our institution's” experience from 1989 to 2003.J Arthroplasty.2009; 24(7): 1051–1060.
15.
FitzgeraldRHJr., NolanD.R., IlstrupD.M., Van ScoyR.E., WashingtonJAII, CoventryM.B.Deep wound sepsis following total hip arthroplasty.J Bone Joint Surg Am.1977; 59(7): 847–855.
16.
TsukayamaD.T., EstradaR., GustiloR.B.Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections.J Bone Joint Surg Am.1996; 78(4): 512–523.
17.
ParviziJ., ZmistowskiB., BerbariE.F.New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society.Clin Orthop Relat Res.2011; 469(11): 2992–2994.
18.
DeirmengianC., KardosK., KilmartinP., CameronA., SchillerK., ParviziJ.Combined measurement of synovial fluid α-Defensin and C-reactive protein levels: highly accurate for diagnosing periprosthetic joint infection.J Bone Joint Surg Am.2014; 96(17): 1439–1445.
19.
BourneR.B., HunterG.A., RorabeckC.H., MacnabJ.J.A six-year follow-up of infected total hip replacements managed by Girdle-stone's arthroplasty.J Bone Joint Surg Br.1984; 66(3): 340–343.
20.
CastellanosJ., FloresX., LlusàM., ChiribogaC., NavarroA.The Girdlestone pseudarthrosis in the treatment of infected hip replacements.Int Orthop.1998; 22(3): 178–181.
21.
ByrenI., BejonP., AtkinsB.L.One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome.J Antimicrob Chemother.2009; 63(6): 1264–1271.
22.
CrockarellJ.R., HanssenA.D., OsmonD.R., MorreyB.F.Treatment of infection with débridement and retention of the components following hip arthroplasty.J Bone Joint Surg Am.1998; 80(9): 1306–1313.
23.
CarlssonA.S., JosefssonG., LindbergL.Revision with gentamicin-impregnated cement for deep infections in total hip arthroplasties.J Bone Joint Surg Am.1978; 60(8): 1059–1064.
24.
OussedikS.I., DoddM.B., HaddadF.S.Outcomes of revision total hip replacement for infection after grading according to a standard protocol.J Bone Joint Surg Br.2010; 92(9): 1222–1226.
25.
BuchholzH.W., ElsonR.A., EngelbrechtE., LodenkämperH., RöttgerJ., SiegelA.Management of deep infection of total hip replacement.J Bone Joint Surg Br.1981; 63-B(3): 342–353.
26.
RautV.V., OrthM.S., OrthM.C., SineyP.D., WroblewskiB.M.One stage revision arthroplasty of the hip for deep gram negative infection.Int Orthop.1996; 20(1): 12–14.
27.
CallaghanJ.J., KatzR.P., JohnstonR.C.One-stage revision surgery of the infected hip. A minimum 10-year followup study.Clin Orthop Relat Res.1999; (369): 139–143.
HanssenA.D.Local antibiotic delivery vehicles in the treatment of musculoskeletal infection.Clin Orthop Relat Res.2005; (437): 91–96.
30.
StockleyI., MockfordB.J., Hoad-ReddickA., NormanP.The use of two-stage exchange arthroplasty with depot antibiotics in the absence of long-term antibiotic therapy in infected total hip replacement.J Bone Joint Surg Br.2008; 90(2): 145–148.
31.
HsiehP.H., HuangK.C., LeeP.C., LeeM.S.Two-stage revision of infected hip arthroplasty using an antibiotic-loaded spacer: retrospective comparison between short-term and prolonged antibiotic therapy.J Antimicrob Chemother.2009; 64(2): 392–397.
32.
BerendK.R., LombardiAVJr., MorrisM.J., BergesonA.G., AdamsJ.B., SnellerM.A.Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality.Clin Orthop Relat Res.2013; 471(2): 510–518.
33.
LanglaisF.Can we improve the results of revision arthroplasty for infected total hip replacement?J Bone Joint Surg Br.2003; 85(5): 637–640.
34.
LuuA., SyedF., RamanG.Two-stage arthroplasty for prosthetic joint infection: a systematic review of acute kidney injury, systemic toxicity and infection control.J Arthroplasty.2013; 28(9): 1490–8.e1.
35.
SpringerB.D., LeeG.C., OsmonD., HaidukewychG.J., HanssenA.D., JacofskyD.J.Systemic safety of high-dose antibiotic-loaded cement spacers after resection of an infected total knee arthroplasty.Clin Orthop Relat Res.2004; 427: 47–51.
36.
PatrickB.N., RiveyM.P., AllingtonD.R.Acute renal failure associated with vancomycin- and tobramycin-laden cement in total hip arthroplasty.Ann Pharmacother.2006; 40(11): 2037–2042.
37.
MasriB.A., PanagiotopoulosK.P., GreidanusN.V., GarbuzD.S., DuncanC.P.Cementless two-stage exchange arthroplasty for infection after total hip arthroplasty.J Arthroplasty.2007; 22(1): 72–78.
38.
HaddadF.S., Muirhead-AllwoodS.K., ManktelowA.R., Bacarese-HamiltonI.Two-stage uncemented revision hip arthroplasty for infection.J Bone Joint Surg Br.2000; 82(5): 689–694.
39.
IbrahimM.S., RajaS., KhanM.A., HaddadF.S.A multidisciplinary team approach to two-stage revision for the infected hip replacement: a minimum five-year follow-up study.Bone Joint J.2014; 96(10): 1312–1318.
40.
HsiehP.H., ShihC.H., ChangY.H., LeeM.S., ShihH.N., YangW.E.Two-stage revision hip arthroplasty for infection: comparison between the interim use of antibiotic-loaded cement beads and a spacer prosthesis.J Bone Joint Surg Am.2004; 86(9): 1989–1997.
41.
HofmannA.A., GoldbergT.D., TannerA.M., CookT.M.Ten-year experience using an articulating antibiotic cement hip spacer for the treatment of chronically infected total hip.J Arthroplasty.2005; 20(7): 874–879.
42.
BiringG.S., KostamoT., GarbuzD.S., MasriB.A., DuncanC.P.Two-stage revision arthroplasty of the hip for infection using an interim articulated Prostalac hip spacer: a 10- to 15-year follow-up study.J Bone Joint Surg Br.2009; 91(11): 1431–1437.
43.
LeungF., RichardsC.J., GarbuzD.S., MasriB.A., DuncanC.P.Two-stage total hip arthroplasty: how often does it control methicillin-resistant infection?Clin Orthop Relat Res.2011; 469(4): 1009–1015.
44.
VolinSJHS, GarvinK.L.Two-stage reimplantation of periprosthetic total joint arthroplasties: do resistant bacteria preclude a good outcome? Proceedings of the 70th Annual Meeting of the American Academy of Orthopaedic Surgeons, 2003.
45.
KilgusD.J., HoweD.J., StrangA.Results of periprosthetic hip and knee infections caused by resistant bacteria.Clin Orthop Relat Res.2002; 404: 116–124.
46.
BeswickA.D., ElversK.T., SmithA.J., Gooberman-HillR., LoveringA., BlomA.W.What is the evidence base to guide surgical treatment of infected hip prostheses? systematic review of longitudinal studies in unselected patients.BMC Med.2012; 10(1): 18.
47.
LeonardH.A., LiddleA.D., BurkeO., MurrayD.W., PanditH.Single- or two-stage revision for infected total hip arthroplasty? A systematic review of the literature.Clin Orthop Relat Res.2014; 472(3): 1036–1042.
48.
EngesæterL.B., DaleH., SchramaJ.C., HallanG., LieS.A.Surgical procedures in the treatment of 784 infected THAs reported to the Norwegian Arthroplasty Register.Acta Orthop.2011; 82(5): 530–537.
49.
SpangehlM.J., MasriB.A., O'ConnellJ.X., DuncanC.P.Prospective analysis of pre-operative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties.J Bone Joint Surg Am.1999; 81(5): 672–683.
50.
AustinM.S., GhanemE., JoshiA., LindsayA., ParviziJ.A simple, cost-effective screening protocol to rule out periprosthetic infection.J Arthroplasty.2008; 23(1): 65–68.
51.
Di CesareP.E., ChangE., PrestonC.F., LiuC.J.Serum interleukin-6 as a marker of periprosthetic infection following total hip and knee arthroplasty.J Bone Joint Surg Am.2005; 87(9): 1921–1927.
52.
LevitskyK.A., HozackW.J., BalderstonR.A.Evaluation of the painful prosthetic joint. Relative value of bone scan, sedimentation rate, and joint aspiration.J Arthroplasty.1991; 6(3): 237–244.
53.
ScherD.M., PakK., LonnerJ.H., FinkelJ.E., ZuckermanJ.D., Di CesareP.E.The predictive value of indium-111 leukocyte scans in the diagnosis of infected total hip, knee, or resection arthroplasties.J Arthroplasty.2000; 15(3): 295–300.
54.
PillS.G., ParviziJ., TangP.H.Comparison of fluorodeoxyglucose positron emission tomography and (111) indium-white blood cell imaging in the diagnosis of periprosthetic infection of the hip.J Arthroplasty.2006; 21(6)(Suppl 2): 91–97.
